Lee JM, Brady MF, Miller A, Moore RG, et al. Cediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005. J Clin Oncol 2024 Oct 3:JCO2400683. doi: 10.1200/JCO.24.00683.
PMID: 39361946